Schizophrenia (SCZ) is an often devastating neuropsychiatric illness with a lifetime prevalence of 0.4%. The current understanding of the polygenic nature of this disease underscores the complexity of understanding SCZ etiology. New and exciting novel findings from the Psychiatric GWAS Consortium (PGC) have identified significant and replicated association for a region on chromosome 1 near MIR137. Meta-analysis of the published PGC GWAS data with a Swedish sample (N=21,856) yielded a top significant SNP of p=1.7X10-9, located approximately 40kb upsteam of the region encoding the MIR137 stem-loop sequence. MIR137 has also been functionally implicated through identification of significant genome wide association for four genes which have confirmed miR-137 target sites (CACNA1C, TCF4, CSMD1, and C10orf26). Analysis of the PGC- GWAS data also shows that predicted miR-137 targets were enriched for association compared with genes matched for size and marker density (p<0.01). These findings suggest that there exists a variant in this region, likely affecting miR-137 function that alters risk for SCZ. However, to date, no functional variants have been reported and linked to SCZ risk. We therefore propose a set of experiments designed to identify both novel and known variants that are the best candidates for functionally affecting either MIR137 or other genes, thereby directly contributing to SCZ risk. This work involves: 1) verification of transcriptional and genomic architecture through novel and innovative techniques, including sequencing of nascent RNA (GRO-seq) and long-read sequencing of select individuals;2) sequencing SCZ cases and controls for identification of novel variants 3) functional annotation using existing databases and data from our work on the region and 4) genotyping of a large case control dataset to determine which variants are associated with SCZ. This will yield highly detailed and prioritized list of variants that are likey to contribute to risk of SCZ in the population. This will provide for the basis of future grant applications molecularly confirming the functional effect of variants on nearby genes and in the SCZ population. This region provides the best opportunity yet to identify pieces to the complex puzzle of SCZ etiology.

Public Health Relevance

Schizophrenia (SCZ) is a devastating disease which lowers quality of life and has increased morbidity. This project will investigate a novel SCZ association on chromosome 1 through identification of potentially functional variants that are associated with SCZ. This is the first stage of work in an ultimate goal of identifying the variant directly responsible for SCZ risk, creating a better understanding of the biology and underlying etiology of this devastating disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21MH099370-01
Application #
8428192
Study Section
Behavioral Genetics and Epidemiology Study Section (BGES)
Program Officer
Meinecke, Douglas L
Project Start
2013-02-07
Project End
2014-12-31
Budget Start
2013-02-07
Budget End
2013-12-31
Support Year
1
Fiscal Year
2013
Total Cost
$228,000
Indirect Cost
$78,000
Name
University of North Carolina Chapel Hill
Department
Genetics
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599